Study of Rivoglitazone in Type 2 Diabetes Mellitus

PHASE3CompletedINTERVENTIONAL
Enrollment

1,912

Participants

Timeline

Start Date

April 23, 2007

Primary Completion Date

February 12, 2009

Study Completion Date

February 12, 2009

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

Pioglitazone

45 mg over-encapsulated tablet administered orally, once daily

DRUG

Placebo

Rivoglitazone-matching placebo administered as a tablet orally, once daily or a pioglitazone-matching placebo administered as an over-encapsulated tablet orally, once daily capsule

DRUG

Rivoglitazone

1.0 mg tablet administered orally, once daily

DRUG

Rivoglitazone

1.5 mg tablet administered orally, once daily

Trial Locations (183)

Unknown

Anniston

Birmingham

Hoover

Muscle Shoals

Hot Springs

Jonesboro

Little Rock

Buena Park

Garden Grove

Huntington Park

Los Angeles

Paramount

Sacramento

San Diego

Walnut Creek

West Covina

West Hills

Denver

Delray Beach

Jacksonville

Merritt Island

Miami

Pembroke Pines

Tampa

Honolulu

Boise

Chicago

Evansville

Indianapolis

Wichita

Madisonville

New Orleans

Slidell

Springfield

Portage

Southfield

St Louis

Voorhees Township

Syracuse

Morehead City

Salisbury

Statesville

Winston-Salem

Cincinnati

Cleveland

Delaware

Lyndhurst

Marion

Oklahoma City

Tulsa

Portland

Beaver

Philadelphia

Charleston

Columbia

Cleveland

Kingsport

New Tazewell

Carrollton

Conroe

Corpus Christi

Dallas

El Paso

Garland

Irving

Midland

San Antonio

Richmond

Olympia

Milwaukee

Loma Verde

Zárate

San Vicente

Feldkirch

Graz

Vienna

Santiago

Santiago

Temuco

Horní Město

Karlovy Vary

Prague

Ústí nad Labem

Vysoký Les

Zlín

Znojmo

Aschaffenburg

Augsburg

Bad Oeynhausen

Berlin

Bosenheim

Dortmund

Dresden

Friedrichsthal

Giessen

Halle

Hamburg

Kippenheim

Mainz

Rehlingen

Riesa

Saarbrücken

Saarlouis

Siegen

Wiesbaden

Balatonfüred

Békéscsaba

Budapest

Debrecen

Eger

Gyula

Kaposvár

Szentes

Hyderabad

Vijayawada

Visakhapatnam

Vasanth Nagar

Mylapore

Shāstri Nagar

Ahmedabad

Gandhinagar

Karnāl

Sarwa C.

Bangalore

Belagavi

Mangalore

Kochi

Indore

Mumbai

Dhantoli

Rāmdaspeth

Jaipur

Coimbatore

Aligarh

Daugavpils

Kuldīga

Liepāja

Riga

Cuernavaca

Monterrey

Metepec

Mérida

Aguascalientes

Durango

Puebla City

La Victoria

Magdalena del Mar

San Juan de Miraflores

San Martín de Porres

Monterrico

Lima

Rio Piedras

San Juan

Arad

Brasov

Bucharest

Satu Mare

Târgu Mureş

Belgrade

Kragujevac

Niš

Subotica

Zemun

Bratislava

Lučenec

Moldava nad Bodvou

Nové Mesto nad Váhom

Považská Bystrica

Žilina

Johannesburg

Port Elizabeth

Dnipro

Kharkiv

Kiev

Lviv

Simferopol

Edmonton

Sunbury-on-Thames

Addlestone

Wakefield

Swindon

Chippenham

00983

Villa Fontana

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Daiichi Sankyo

INDUSTRY

NCT00484198 - Study of Rivoglitazone in Type 2 Diabetes Mellitus | Biotech Hunter | Biotech Hunter